|
Characteristics
|
PreDSCs
|
MSCs
|
References
|
|---|
|
Antigen phenotype
|
Table 1
|
Table 1
|
[5, 19, 36]
|
|
ISCT minimal criteria
|
+
|
+
|
[19, 37]
|
|
Decidualization
|
PRL (mRNA+, protein+)
|
PRL (mRNA+, protein−)
|
[5]
|
|
Mesenchymal differentiation
|
+
|
+
|
This work, [37]
|
|
Cell contractility
|
+
|
+
|
[19, 29]
|
|
Stem cell markers
|
+
|
+
|
This work,[43]
|
|
Clonogenicity
|
+
|
+
|
This work, [45]
|
|
Apoptosis resistance
|
+
|
+
|
[27, 30]
|
|
Hematopoietic cell supportive activity
|
+
|
+
|
[18, 46]
|
|
Survival in xenotransplants
|
+
|
+
|
This work, [47, 48]
|
|
Perivascular location
|
+
|
+
|
[19, 49]
|
|
In vivo and in vitro immunoregulatory activity
|
+
|
+
|
This work [5, 7, 23]
|
